Kenna, George A.

Pharmacological approaches to reducing craving in patients with alcohol use disorders

Haass-Koffler, C. L., Leggio, L., & Kenna, G. A. (2014) · CNS Drugs

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 83

Pharmacotherapy for alcoholic patients with alcoholic liver disease

Vuittonet, C. L., Halse, M., Leggio, L., Fricchione, S. B., Brickley, M., Haass-Koffler, C. L., Tavares, T., Swift, R. M., & Kenna, G. A. (2014) · American Journal of Health-System Pharmacy

Alcohol Consumption and Health EffectsSubstance Abuse Treatment and Outcomes

Cited by 51

Can the short index of problems (SIP) be improved? Validity and reliability of the three-month SIP in an emergency department sample.

Kenna, G. A., Longabaugh, R., Gogineni, A., Woolard, R. H., Nirenberg, T. D., Becker, B., Minugh, P. A., Carty, K., Clifford, P. R., & Karolczuk, K. (2005) · Journal of Studies on Alcohol

Substance Abuse Treatment and OutcomesPsychometric Methodologies and Testing

Cited by 40

Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: Exploratory findings

Kenna, G. A., Zywiak, W. H., Swift, R. M., McGeary, J. E., Clifford, J. S., Shoaff, J. R., Fricchione, S., Brickley, M., Beaucage, K., Haass-Koffler, C. L., et al. (2014) · Alcohol

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Cited by 20